#9: dlupy: ctic this week
whats the word this week on ctic? will it get a pop |
February 8, 2010
09:08:56 AM |
#8: Stock News Bot: Stock News CTIC, Cell Therapeutics, Inc. Announces Institutional Investors Purchase $30 Million of Preferred Stock and Warrants
SEATTLE,
Jan. 13 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (Nasdaq and
... |
January 18, 2010
07:13:43 AM |
#7: TheMachine: CTIC Stock News : Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines
NEW
ORLEANS, Dec. 8 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
("CTI")... |
December 10, 2009
11:50:00 AM |
#6: TheMachine: CTIC Stock News : New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology
Company to Host Investor and Analyst Meeting on December 5, 2009
Dec. 2, 2009... |
December 6, 2009
12:24:07 PM |
#5: TheMachine: CTIC Stock News : Genes Identified That Enhance Tumor Cell Sensitivity to CTI's Cancer Drug Brostallicin
Identifies potential clinical trial strategies for personalized approach to cancer... |
April 22, 2009
12:15:21 AM |
#4: Jason: Cell Therapeutics CTIC Stock Price Appreciation
CTIC stock has had a tremendous performance over the last month. Cell... |
April 9, 2009
09:36:33 PM |
#3: Stock News Bot: CTIC Stock CTI Receives the Second Payment of $6.5 million Associated with the Sale of Interest in Zevalin Joint Venture
SEATTLE, April 6 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq... |
April 7, 2009
09:51:29 AM |
#2: Stock News Bot: CTIC Cell Therapeutics Satisfies NASDAQ Listing Requirements to Continue to Trade on NASDAQ Capital Market Cell Therapeutics Satisfies NASDAQ Listing Requirements to Continue to Trade on NASDAQ Capital Market SEATTLE, April 3 /PRNewswire-FirstCall/ -- C
SEATTLE, April 3 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq... |
April 3, 2009
04:22:18 PM |
#1: Stock News Bot: CTIC News Rodman & Renshaw, LLC Initiates Coverage of Cell Therapeutics, Inc. With A Market Outperform Rating
NEW YORK--(BUSINESS WIRE)--Rodman & Renshaw, LLC initiated research coverage... |
January 8, 2007
11:02:00 AM |
